Why the study?
Does adrenalectomy for synchronous versus metachronous adrenal metastasis affect overall survival in patients with NSCLC?
Does adrenalectomy for synchronous versus metachronous adrenal metastasis affect overall survival in patients with NSCLC?
While synchronous adrenal metastases in NSCLC are associated with shorter median overall survival compared to metachronous metastases after adrenalectomy, both groups can achieve long-term survival in about 25% of cases.
Synchronous metastases confer shorter post-adrenalectomy survival in NSCLC; leaves open whether resection improves outcomes versus systemic therapy alone.
For an isolated adrenal metastasis from NSCLC, patients with a synchronous metastasis who underwent adrenalectomy had a shorter median overall survival than those with a metachronous metastasis. However, a durable long-term survival is achieved in approximately 25% in both groups.
No takes yet. Share an insight, caveat, or question.
Tanvetyanon et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: